Balance Sheet Data

Avidity Biosciences, Inc. (RNA)

$15.35

-1.45 (-8.63%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 3.0994.58328.14405.54610.731,089.063,106.168,859.2325,267.8272,067.53
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 1.572.317.7419.4819.2654.95156.72446.971,274.843,636.02
Accounts Payable (%)
Capital Expenditure -0.05-0.23-1.09-3.74-2.82-5.78-16.49-47.02-134.11-382.51
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.